Research location
Ganzhou
Jiangxi, China
Advertisement
Research activity in Ganzhou
Jiangxi, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 27 trials and 30 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Ganzhou
27 linked trials · page 1 of 1TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerNCT07047365 · 2025-07-25 · 2 site observations
RECRUITING
Development of an AI-Agent for Urological Disease Diagnosis and TreatmentNCT07721935 · 2025-04-01 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1NCT06767514 · 2025-02-27 · 1 site observation
RECRUITING
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 1 site observation
RECRUITING
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)NCT04974138 · 2024-08-22 · 1 site observation
RECRUITING
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT GenotypeNCT04974151 · 2024-08-22 · 1 site observation
RECRUITING
A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene AbnormalityNCT06496490 · 2024-08-06 · 1 site observation
RECRUITING
A Study of YL202 in Selected Patients With Advanced Solid TumorsNCT06107686 · 2023-12-15 · 1 site observation
RECRUITING
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsNCT05899608 · 2023-10-26 · 1 site observation
RECRUITING
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsNCT05914116 · 2023-08-17 · 1 site observation
RECRUITING
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast CancerNCT05851014 · 2022-01-14 · 1 site observation
RECRUITING
Integrative Analysis of Large-cell Lung CancerNCT02917369 · 2016-01-01 · 1 site observation
RECRUITING
A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of BreastNCT02897700 · 2013-01-01 · 1 site observation
RECRUITING
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic CholangiocarcinomaNCT07691515 · 2026-07-01 · 1 site observation
NOT_YET_RECRUITING
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsNCT06738979 · 2025-03-20 · 1 site observation
COMPLETED
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe AsthmaNCT06376045 · 2024-05-24 · 1 site observation
TERMINATED
Budesonide/Formoterol Inhalation Powder in Adults With AsthmaNCT07790159 · 2024-02-21 · 1 site observation
COMPLETED
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast CancerNCT06115902 · 2023-11-17 · 1 site observation
COMPLETED
A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung CancerNCT05990127 · 2023-11-14 · 1 site observation
NOT_YET_RECRUITING
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19NCT05855395 · 2023-05-26 · 1 site observation
UNKNOWN
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung CancerNCT05042375 · 2022-09-08 · 1 site observation
UNKNOWN
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerNCT05365178 · 2022-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast CancerNCT05433480 · 2022-05-25 · 1 site observation
UNKNOWN
A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung CancerNCT05353257 · 2022-05-17 · 2 site observations
ACTIVE_NOT_RECRUITING
To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan IsoproxilNCT06500689 · 2021-12-30 · 2 site observations
COMPLETED
Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial HypertensionNCT04483115 · 2020-11-16 · 1 site observation
COMPLETED
Influence of rTMS on Symptoms and Cognitive Function in Patients With Psychiatric DisordersNCT04055181 · 2018-12-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.